BioPrint® is a large, homogenous pharmacology and ADME database, which provides a unique resource for supporting decision making in drug
discovery. The database is composed of three main data sets:
chemical descriptors (structures and chemical information, 2D and 3D descriptors),
in vitro data also considered as compound descriptors,
collected and curated in vivo effects of drugs.
Chemical and pharmacophoric descriptors together form a data set for QSAR generation supporting organ safety modeling.
BioPrint® positions a new drug candidate in the context of marketed drugs, anticipating potential in vivo liabilities, predicting off-target activities, and ADME
characteristics (Drug profile interpretation). In another application, BioPrint® serves to identify secondary targets that are not genetically parented
to a test target (Target profile design). Both these applications are available as custom services without need of subscription to BioPrint®.